Introduction
The metabolic enzymes in the liver are important in excretion of drugs, toxic substances and other xenobiotics from the body (Gonzalez, 1988) . Understanding the metabolism of a drug candidate is very important for estimating individual differences in clinical efficacy or potential adverse effects, since many of the differences are caused by individual differences in specific pathways or activities in the metabolism of drug candidates. Wide species differences have been reported in the characteristics of metabolic enzymes (Martignoni et al., 2006) , and thus enzymes prepared using human material should be used to evaluate metabolism in humans. Primary hepatocytes provide a complete set of phase I and II drug metabolizing enzymes as well as several transporters and co-factors, and are therefore a highly attractive tool for evaluation of metabolism, active transport, and enzyme induction (Soars et al., 2007) . Cryopreserved primary hepatocytes are commercially available at any time on demand, but their stability during storage is only certified for up to 6 months (Li et al., 1999; Rialland et al., 2000) . This study employed only limited lots of hepatocytes, owing to the limited availability of cryopreserved hepatocytes at the starting point of the study. We confirmed the stability of the viability, metabolic enzyme activity, and CYP3A4/5 induction of cryopreserved human hepatocytes stored for 14 years after preparation.
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Thawing and seeding of cryopreserved human hepatocytes
For the enzyme activity analysis, cryopreserved hepatocytes were thawed and suspended in DMEM using a previously reported procedure (Li et al., 1999) with minor modifications. The hepatocyte suspension was seeded at a density of 3.0 × 10 5 viable cells/0.5 mL/well in 24-well plates.
For the induction study, hepatocytes were thawed in a water bath at 37°C and suspended in Leibovitz's L-15 medium containing 10% FBS and 0.5 g/L glucose. The hepatocyte suspension was centrifuged at 55 × g for 3 min, and the hepatocytes were re-suspended in Long Term Culture medium containing 10% FBS. The hepatocyte suspension was seeded at a density of 6.0 × 10 5 viable cells/1 mL/well in 12-well collagen coated plates. 
Measurement of viability
Trypan blue (0.15% to 0.2%) was added to the hepatocyte suspension, and the viability of the cells was determined as the percentage of cells excluding the dye compared to the total cell number.
Measurement of CYP3A4/5 activity
Testosterone 6β-hydroxylation activity was measured to determine the CYP3A4/5 activity.
Testosterone (50 µmol/L) was added to each hepatocyte suspension, and incubated for 1 h under 5% CO 2 at 37°C. After incubation, the hepatocyte suspension was extracted by ethyl acetate and the extracted fraction was dried and re-suspended in methanol/ultrapure water (1:1). This solution was subjected to high-performance liquid chromatography (HPLC) with a TSKgel ODS120T (5 μm, 250 × 4.6 mm I.D.; TOSOH, CORPORATION. Tokyo, Japan) and a UV detector (254 nm). All experiments were performed in duplicate.
Measurement of 7-ethoxycoumarine metabolic activity
The metabolic activity of 7-ethoxycoumarine (7-EC) was evaluated as a marker for CYP1A2 activity, and 7-hydroxycoumarine glucuronide (7-HCG) and 7-hydroxycoumarine sulfate (7-HCS) formation through 7-hydroxycoumarine (7-HC) were analyzed to determine glucuronidation and sulfation activity, respectively. 7-EC (75 µmol/L) was added to the hepatocyte suspension, and incubated for 4 h under 5% CO 2 at 37°C. The reaction was terminated by freezing at -30°C. After thawing, the hepatocyte suspension was centrifuged at 1500 × g for 10 min and the supernatant was subjected to HPLC with a SUPERCOSIL LC-8
(5 μm, 50 × 4.6 mm I.D.; Sigma-Aldrich) and a UV detector (325 nm) (Hiller and Cole, 1995) . Each study was performed in duplicate.
Evaluation of CYP3A4/5 induction activity
The hepatocytes were cultured with FBS for 1 day to induce attachment to the plates and then for 3 days without FBS for stabilization in Long-Term culture medium under 5% CO 2 at 37°C. Then, the hepatocytes were treated with Long-Term Culture Medium containing rifampin (10 µmol/L) for 3 days. The rifampin-containing media was changed every day.
After treatment with rifampin, the hepatocytes were rinsed with fresh media and incubated with media containing testosterone (250 µmol/L) for 2 h, and the formation of 6β-hydroxytestosterone was analyzed by HPLC as described above ("Measurement of CYP3A4/5 activity").
Results and Discussion
Human hepatocytes are widely used to evaluate drug metabolism, active transport, and enzyme induction (Sahi et al., 2010) , and are also used for evaluation of drug-induced liver injury (DILI). HepG2, HepaRG and inducible pluripotent stem cells into hepatocyte-like cells (iPSC-HHs) are used to evaluate drug metabolism and hepatotoxicity (Saito et al., 2016; Krueger et al., 2014) . However, HepG2 and HepaRG are poor for detection of hepatotoxicity, due to their limited function and production of metabolic enzymes. iPSC-HHs would be an ideal research tool, but production of cells possessing complete hepatocyte function is exceedingly difficult, although further progress is expected. Cryopreserved hepatocytes that have been stored stably in vapor phase of liquid nitrogen, can be transported over long distances more easily, and can be used at any time the need arises. In this series of studies, we evaluated the stability of human primary hepatocytes during cryopreservation over more than a decade as a tool for investigation of drug metabolism.
Viability, as evaluated by the trypan blue exclusion method (McLimans et al., 1957) , did not change during the 14 years of storage in any of the 3 lots of hepatocytes (Figure 1 ), indicating that the integrity of the cytoplasmic membrane was sustained during storage.
CYP1A2 and CYP3A4/5 are localized in the microsomal membrane (Gonzalez, 1988) . A slight decrease in CYP3A4/5 activity was observed after 8 years, compared with activity evaluated in the first 7 years, but the residual activity ratio at 14 years, compared with that at 7 years, was about 75% (Figure 2 ). 7-EC is metabolized to 7-HC by CYP1A2, and 7-HC is subsequently, metabolized to 7-HCG by UGT and to 7-HCS by SULT. The total amount of 7-HC, 7-HCG and 7-HCS, which indicates the actual 7-HC formation activity, did not decrease after 14 years ( Figure 3 ).
Formation of 7-HCG and 7-HCS from 7-HC were analyzed as markers for the activity of SULTs are located in the cell cytoplasm. UGT activity, expressed as the ratio of the 7-HCG concentration to the 7-HC concentration (7-HCG/7-HC), was maintained during the 14 years of preservation (Figure 4 ). However, SULT activity, expressed as the ratio of the 7-HCS concentration to the 7-HC concentration (7-HCS/7-HC), showed a clear tendency to decrease (Figure 4 ), and this finding was consistent with reports that the SULT activity in rat hepatocytes was decreased by cryopreservation (Utesch et al., 1992) . CYP3A4/5 induction, which is triggered by pregnane X receptor activation (Chai et al., 2013) , was not changed during preservation, and CYP3A4/5 activity after rifampin treatment was maintained at a high level throughout preservation ( Figure 5 ), indicating that DNA to RNA transcription and subsequent protein synthesis were maintained, to deliver a sufficient amount of CYP3A4/5 enzyme.
These results demonstrate the survival of hepatocytes for more than a decade. It should be noted that this study was performed only in limited lots of hepatocytes. This practical information concerning long-term hepatocyte stability should lead to improvements in the use of cryopreserved hepatocytes, which are an excellent tool for qualitative evaluation of drug metabolism and metabolism mediated drug-drug interactions.
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